Literature DB >> 6330612

Pathophysiology of hemifacial spasm: III. Effects of facial nerve decompression.

V K Nielsen, P J Jannetta.   

Abstract

We studied 59 patients with hemifacial spasm before decompression of the facial nerve in the cerebellopontine angle. Fifty-three patients were reexamined 1 week later, and 30 patients after 2 to 8 months. Within 1 week, ephaptic transmission disappeared in 23% and changed from bidirectional to unidirectional in 45%. After-discharges disappeared in 64% and were mild in 34%. Synkinesis after supraorbital nerve stimulation disappeared in 53%, and the blink reflex amplitude became normal. After 2 to 8 months, ephaptic transmission was abolished in 73% and unidirectional in 17%. After-discharges and synkinesis disappeared in 90%, and the latency of the blink reflex decreased. It is concluded that decompression stops ectopic/ ephaptic excitation due to decrease in the interstitial resistance, and enables remyelination.

Entities:  

Mesh:

Year:  1984        PMID: 6330612     DOI: 10.1212/wnl.34.7.891

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  20 in total

1.  Hemifacial spasm in a child.

Authors:  N Milani; V Scaioli; S Giombini; M Grisoli; L Angelini
Journal:  Childs Nerv Syst       Date:  1991-12       Impact factor: 1.475

2.  Time course of symptom disappearance after microvascular decompression for hemifacial spasm.

Authors:  Eun-Tak Oh; Eunyoung Kim; Dong-Keun Hyun; Seung Hwan Yoon; Hyeonseon Park; Hyung-Chun Park
Journal:  J Korean Neurosurg Soc       Date:  2008-10-30

3.  The value of lateral spread response monitoring in predicting the clinical outcome after microvascular decompression in hemifacial spasm: a prospective study on 100 patients.

Authors:  Ahmed El Damaty; Christian Rosenstengel; Marc Matthes; Joerg Baldauf; Henry W S Schroeder
Journal:  Neurosurg Rev       Date:  2016-04-06       Impact factor: 3.042

4.  Botulinum toxin treatment of hemifacial spasm.

Authors:  J S Elston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-07       Impact factor: 10.154

5.  Intracranial microvascular decompression for "cryptogenic" hemifacial spasm, trigeminal and glossopharyngeal neuralgia, paroxysmal vertigo and tinnitus: II. Clinical study and long-term follow up.

Authors:  R Michelucci; C A Tassinari; G Samoggia; F Tognetti; F Calbucci
Journal:  Ital J Neurol Sci       Date:  1986-06

6.  Recordings from the facial nucleus in the rat: signs of abnormal facial muscle response.

Authors:  A R Møller; C N Sen
Journal:  Exp Brain Res       Date:  1990       Impact factor: 1.972

7.  Magnetic resonance tomographic angiography: diagnostic value in trigeminal neuralgia.

Authors:  F Umehara; K Kamishima; N Kashio; K Yamaguchi; T Sakimoto; M Osame
Journal:  Neuroradiology       Date:  1995-07       Impact factor: 2.804

8.  Pathophysiology of hemimasticatory spasm.

Authors:  G Cruccu; M Inghilleri; A Berardelli; G Pauletti; C Casali; P Coratti; G Frisardi; P D Thompson; M Manfredi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-01       Impact factor: 10.154

Review 9.  The cranial nerve vascular compression syndrome: II. A review of pathophysiology.

Authors:  A R Møller
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

10.  Botulinum toxin treatment in patients with focal dystonia and hemifacial spasm. A multicenter study of the Italian Movement Disorder Group.

Authors:  A Berardelli; A Formica; B Mercuri; G Abbruzzese; A Agnoli; R Agostino; T Caraceni; F Carella; G De Fazio; D De Grandis
Journal:  Ital J Neurol Sci       Date:  1993-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.